DAFTAR PUSTAKA

1. Wannamethee SG, Shaper AG, Morris RW, Whincup PH.

Measures of adiposity in the identification of metabolic
abnormalities in elderly men. Am J Clin Nutr. 2005; 81:1313-21
2. Eckel RH, Krauss RM. Defenition, diagnosis and classification of
diabetes mellitus and its complications. Part 1: diagnosis and
classification of diabetes mellitus, provisional report of a WHO
consultation. Diabet Med. 1998: 15; 539-53.
3. Reaven GM. Role of insulin resistance in human disease. Diabetes.
1988; 37:1595-607
4. Kaplan NM. The deadly quartet. Upper body obesity, glucose
intolerance, hypertrigliseridemia, and hypertension. Arch Intern
Med. 1989; 149:1514-20
5. Alberti KGMM, Zimmet PZ. For the WHO consultation, definition,
diagnosis and classification of diabetes mellitus and its
complications: Part 1. Diagnosis and classification of diabetes
melitus. Provision report of a WHO consulation. Diabet Med. 1998;
15:539-53
6. Reaven GM. Role of insulin resistance in human disease. Diabetes.
1988; 37:15951607.
7. Mc Phee SJ, Papadakis MA, Rabow MW. Prevention of overweight
and obesity. In: Lange Current Medical Diagnosis & Treatment.
California: Mc Graw Hill; 2011: 14-15.
8. Grundy SM, Cleeman JI, Daniels SR. et al. Diagnosis and
management of the metabolic syndrome an American Heart
Association/National Heart, Lung, and Blood Institute scientific
statement. Circulation. 2005; 112: 2735-2752.

Universitas Sumatera Utara

9. Bodhy W, Manampiring AE. Prevalensi sindroma metabolik pada
remaja di kota Tomohon. Manado: Universitas Sam Ratulangi,
2011.
10. Petrucelli OM. The metabolic syndrome. Northeast Florida
Medicine. 2008; Vol.59, No.3:18-21
11. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic
syndrome among U.S.adult: findings from the Third National Health
and Nutrition Examination Survey. JAMA. 2002; 287:356-9.
12. Eckel RH, Grundy SM, Zimmet P. The Metabolic Syndrome.
Lancet. 2005; 365:1415-28
13. Soegondo S. Atherogenic dyslipidemia and the metabolic
syndrome clinical practice. Indones J Intern Med 2005; 37:177-183.
14. Soewondo P, Purnamasari D, Oemardi M, Waspadji S, Soegondo
S. Prevalence of metabolic syndrome using NCEP/ATP III riteria in
Jakarta, Indonesia: The Jakarta primary non-communicable
disease risk factors surveillance 2006. Indones J Intern Med. 2010;
42:199-203).
15. Serebruany VL, Malinin A, Ong S, Atar D. Patients with metabolic
syndrome exhibit higher platelet activity than those with
conventional risk factors for vascular disease. J Thromb
Thrombolysis. 2008; 25:207-213
16. Kotani K, Sakane N, Saiga K, Mu H, Kurozawa Y. Clustered
components of the metabolic syndrome and platelet counts in
Japanese females. Clin Chem Lab Med. 2007; 45:376-379
17. Harrison P, Keeling D. Clinicat test of platelet function. In:
Michelson AD (ed.). Platelets, 2nd edition. New York: Elsevier Inc.
2007; 445-74.
18. Zhou L, Schmaier AH. Platelet Aggregation Testing in Platelet-Rich
Plasma: Description of Procedure with the Aim to Develop
Standards in the Field. Am J Clin Pathol. 2005; 123:172-183.

Universitas Sumatera Utara

19. George JN. Platelets. Lancet. 2000; 355:1531-1539.
20. Tavil Y, Sen N, Yazici HU et al. Mean platelet volume in patients
with metabolic syndrome and its relationship with coronary artery
disease. Thrombosis Research. 2007; 120:245-250
21. Shah B, Sha D, Xie D, Mohler ER, Berger JS. The relationship
between diabetes mellitus, metabolic syndrome, and platelet
activity as measured by mean platelet volume. Epidemiology/Health
Services Reasearch. care.diabetesjournals.org. 1-5
22. White JG. Platelet structure. In: Michelson AD, editor. Platelets
second edition. Minnesota: Department of laboratory medicine and
pathology, University of Minnesota, 2007.p.45-71
23. Oesman F, Setiabudy RD. Fisiologi hemostasis dan fibrinolisi.
Dalam: Setiabudy RD, penyunting. Hemostasis dan trombosis.
Edisi ketiga. Jakarta, 2007. h.1-8
24. Italiano JE. The Structure and Production of Blood Platelets. In:
Gresele P, Fuster V, Page JA, editors. Platelets in hematologic and
cardiovascular disorders. United Kingdom: Cambridge University
Press, 2008. p.1-15
25. Kaushansky K, Roth GJ. Megakaryocytes and Platelets. In : Greer
JP, Foerster J, Lukens JN, editors. Wintrobe`s Clinical Hematology.
11th ed. USA: Lippincott Williams and Wilkins, 2004. p.619-34.
26. Miller JL, Rao K. Blood Platelets and von Willebrand Disease. In :
McPherson RA, Pincus MR, editors. Henry`s Clinical Diagnosis and
Management by Laboratory Methods. 21st ed. USA: Elsevier, 2007.
p. 74765
27. Ghumlas AK, Gader AG. The blood platelet: An intriguing cell.
2013; 111

Universitas Sumatera Utara

28. Ikeda Y, Matsubara Y, Kamata T. Platelet Immunology: Structure,
functions and polymorphisms of membrane glycoproteins. In:
Gresele P, Fuster V, Page JA, editors. Platelets in hematologic and
cardiovascular disorders. UK, Cambridge University Press, 2008.
p.2130
29. Calverley DC, Maness LJ. Platelet Function in Hemostasis and
Thrombosis. In : Greer JP, Foerster J, Lukens JN, editors.
th
Wintrobe`s Clinical Hematology. 11 ed. USA, Lippincott Williams
and Wilkins, 2004. p.65169
30. Brass LF, Stalker TJ. Mechanism of Platelet Activation. In : Gresele
P, Fuster V, Page JA, editors. Platelets in Hematologic and
Cardiovascular Disorders. UK, Cambridge University Press, 2008.
p.3748
31. Watson SP, Harrison P. The vascular function of platelets. In :
Hoffbrand AV, Catovsky D, Tuddenham EG, editors. Postgraduate
Haematology 5th ed. USA, Blackwell Publishing, 2005. p. 80824.
32. Michelson AD, Furman MI. Markers of platelet activation and
granule secretion. In: Quinn M, Fitzgerald D, editors. Platelet
function: assessment, diagnosis and treatment. New Jersey,
Humana Press, 2005. p.307
33. Shantsila E, Watson T, Lip GYH. Laboratory investigation of
platelets. In: Gresele P, Fuster V, Page JA, editors. Platelets in
hematologic and cardiovascular disorders. UK, Cambridge
University Press, 2008. p. 128131
34. The British Society for Hematology (BSCH) hemostasis and
thrombosis task force. Guidelines on platelet function testing. J Clin
Pathol. 1988; 41: 1322-30

Universitas Sumatera Utara

35. Nilsson IM, Maggnusson S, Borchgrevink C. The duke and ivy
methods for determination of the bleeding time. Thromb Diath
Haemorrh. 1963; 10: 223-32
36. Jarvis GE. Platelet aggregation. In: Gibbins JM, Smith MPM,
editors. Platelets and megakaryocytes. New Jersey, Humana
Press, 2004 p.6576
37. White MM, Jennings LK. Laboratory evaluation of platelet function.
In: White MM, Jennings LK. Platelet protocols; Research and
Clinical Laboratory Procedures. California, Academic Press, 1999.
p.2758
38. Pagana KD. Platelet aggregation. In: Pagana KD, Pagana TJ,
editors. manual diagnostic and laboratory tests. USA, Mosby
Elsevier, 2006. p.40507
39. Wirawan R. Nilai rujukan pemeriksaan agregasi trombosit dengan
adenosin difosfat pada orang Indonesia dewasa normal di Jakarta.
Dalam : Majalah Kedokteran Indonesia, Vol 57, No 7, 2007. p.212
19.
40. Castellone D. Overview of hemostasis and platelet physiology. In:
Ciesla B, Caldwell B, Finnegan K, et al (ed). Hematology in
practice. Philadelphia: F.A. Davis Company. 2007; 232-237
41. Jennings LK, White MM. Platelet aggregation. In: Michelson AD,
editor. Platelets 2nd edition, New York, Elsevier Inc, 2007
42. Perry D, Todd T. Practical hemostasis. A practical guide to
laboratory haemostasis. Platelet function testing: light transmission
aggregometry (LTA). 2011
43. OMalley T, Langhorne P, Elton RA, Stewart C. Platelet size in
stroke patients. American heart association. 1995; 26:995-99
44. Zimmet P, Alberti KGMM, Kaufman F,et al. International Diabetes
Federation (IDF). The IDF Consensus Worldwide Definition Of The
Metabolic Syndrome. 2006: 1-23

Universitas Sumatera Utara

45. International Diabetes Federation. The IDF Consensus Worldwide
Definition of the Metabolic Syndrome: Volume 5, International
Diabetes Federation. 2005
46. Eckel RH, The metabolic syndrome . In : Kasper DL, Fauci AS,
Longo DL, Braunwald E, Hauser SL, Jameson JL, ed. Harrisons
Endocrinology. 2nd ed. New York, NY: McGraw-Hill; 2010 :259-66
47. Petrucelli OM. The metabolic syndrome. Northeast Florida
Medicine.2008; 59: 18-21.
48. Gyakobo M, Amoah AGB, Marbell DAM, Snow RC. Prevalence of
the metabolic syndrome in a rural population in Ghana. BMC
Endocrine Disorder. 2012; 12:3-9
49. Poerjoto P. Sindroma metabolik suatu kelainan metabolik dengan
tanda dan resiko kardiovaskular dan upaya pengendaliannya.
Dalam: Darmono, Suhartono T, Pemayun TGD, Padmomartono FS,
penyunting. Semarang, Naskah lengkap diabetes melitus. Badan
penerbit Universitas Diponegoro, 2007. Hal.233-34
50. Alberti G. Intoduction to the metabolic syndrome. Eur Herat. 2005;
7: D3-D5
51. Williams G, Pickup JC. Handbook of diabetes 2nd. Backwell
science. 1999;8: 53-158
52. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin
Endocrinol Metab. 2004; 89:2548-56
53. Weyer C, Funahashi T, Tanaka S, et al Hypoadiponectinemia in
obesity and type 2 diabetes: close association with insulin
resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001;
86: 1930-35

Universitas Sumatera Utara

54. Fauci AS, Kasper DL, Longo DL, Braunwald E, Hauser SL, et al.
Harrisons Principles of Internal Medicine 17th ed. USA: McGraw-
Hill; 2008.
55. Inoue S, Zimmet P, et al. The Asia-Pacific Perspective: Redefining
Obesity and Its Treatment.WHO Western Asia-Pasific
Perspective. Australia; 2000.
56. Olsson AG, Schwartz GG, Szarel M, et al. High density lipoprotein,
but not low density lipoprotein cholesterol levels influence short
term prognosis after acute coronary syndrome: results from the
MIRACL trial. Eur Heart J 2005; 26: 890-96
57. Feher MD, Richmond W. Lipoprotein: structure and function. In:
Lipid and lipid disorders 2nd ed. Bayer. 1996 : 6-13
58. Ginsberg HN, Golberg IJ. Disorders of lipoprotein metabolism . In:
Fauci AS, Braundwald E, Isselbacher KJ, Wilson JD, Martin JB,
Kasper DL, Hauser SL, Longo DL. Eds. Harrisons Principles of
internal medicine 14th . International edition McGraw-Hill, Health
Professions division 1998; 2: 2138-52
59. Budiono B. Sindroma metabolik dan penyakit kardiovaskuler. Di
dalam: Adam JMF, editor. Obesitas dan sindroma metabolik.
Bandung 2006:118-29
60. Vinik AL, Erbas T, Park TS, Nolan R, Pittenger GL. Platelet
dysfunction in type 2 diabetes. Diabetes Care. 2001; 24: 1476-85
61. Ma J, Xu A, Jia C, Liu L et al. Association of fibrinogen with
metabolic syndrom in rural chinese population. Accepted for
publication. 2009: 17; 486-92.
62. Sargowo D, Andarini S. Pengaruh komposisi asupan makanan
terhadap komponen sindrom metabolik pada remaja. J Kardiol
Indones. 2011; 32: 14-23.

Universitas Sumatera Utara

63. Taniguchi A, Fukushima M, Seino Y, et al. Platelet count is
independently associated with insulin resistance in non-obese
Japanese type 2 diabetic patients. Metabolism.
2003;52:12461249.
64. Turakhia MP, Murphy SA, Pinto TL, et al; Thrombolysis in
Myocardial Infarction Study Group. Association of platelet count
with residual thrombus in the myocardial infarct- related coronary
artery among patients treated with fibri- nolytic therapy for ST-
segment elevation acute myocardial infarction. Am J Cardiol.
2004;94:14061410.

Universitas Sumatera Utara